塩野義製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2017/09/22 | 5,994 | 5,999 | 5,954 | 5,964 | +14 | +0.2% | 955,700 |
2017/09/21 | 5,980 | 5,999 | 5,934 | 5,950 | +48 | +0.8% | 1,266,800 |
2017/09/20 | 5,914 | 5,963 | 5,893 | 5,902 | -57 | -1% | 1,390,700 |
2017/09/19 | 6,005 | 6,011 | 5,945 | 5,959 | -4 | -0.1% | 1,522,000 |
2017/09/15 | 5,894 | 5,984 | 5,877 | 5,963 | +144 | +2.5% | 2,234,900 |
2017/09/14 | 5,820 | 5,874 | 5,808 | 5,819 | -18 | -0.3% | 1,207,800 |
2017/09/13 | 5,848 | 5,875 | 5,794 | 5,837 | -17 | -0.3% | 909,700 |
2017/09/12 | 5,827 | 5,868 | 5,807 | 5,854 | +57 | +1% | 1,221,000 |
2017/09/11 | 5,740 | 5,803 | 5,717 | 5,797 | +125 | +2.2% | 1,432,100 |
2017/09/08 | 5,641 | 5,702 | 5,625 | 5,672 | -69 | -1.2% | 2,873,900 |
2017/09/07 | 5,747 | 5,798 | 5,720 | 5,741 | +11 | +0.2% | 964,300 |
2017/09/06 | 5,700 | 5,741 | 5,647 | 5,730 | +41 | +0.7% | 1,165,800 |
2017/09/05 | 5,720 | 5,729 | 5,668 | 5,689 | -36 | -0.6% | 818,500 |
2017/09/04 | 5,756 | 5,769 | 5,709 | 5,725 | -68 | -1.2% | 792,500 |
2017/09/01 | 5,813 | 5,834 | 5,741 | 5,793 | -2 | ±0% | 1,241,000 |
2017/08/31 | 5,811 | 5,822 | 5,687 | 5,795 | -15 | -0.3% | 1,595,100 |
2017/08/30 | 5,834 | 5,870 | 5,806 | 5,810 | +14 | +0.2% | 1,033,100 |
2017/08/29 | 5,763 | 5,814 | 5,720 | 5,796 | +12 | +0.2% | 1,047,600 |
2017/08/28 | 5,733 | 5,793 | 5,732 | 5,784 | +103 | +1.8% | 1,318,000 |
2017/08/25 | 5,682 | 5,703 | 5,665 | 5,681 | +54 | +1% | 606,700 |
2017/08/24 | 5,600 | 5,670 | 5,599 | 5,627 | -5 | -0.1% | 805,400 |
2017/08/23 | 5,628 | 5,698 | 5,618 | 5,632 | +39 | +0.7% | 1,030,400 |
2017/08/22 | 5,615 | 5,648 | 5,589 | 5,593 | -20 | -0.4% | 850,700 |
2017/08/21 | 5,674 | 5,715 | 5,610 | 5,613 | -80 | -1.4% | 988,000 |
2017/08/18 | 5,660 | 5,723 | 5,651 | 5,693 | -40 | -0.7% | 1,173,900 |
2017/08/17 | 5,741 | 5,780 | 5,709 | 5,733 | +15 | +0.3% | 992,300 |
2017/08/16 | 5,687 | 5,724 | 5,676 | 5,718 | +8 | +0.1% | 1,044,500 |
2017/08/15 | 5,669 | 5,738 | 5,669 | 5,710 | +46 | +0.8% | 1,059,800 |
2017/08/14 | 5,735 | 5,758 | 5,652 | 5,664 | -127 | -2.2% | 1,355,100 |
2017/08/10 | 5,815 | 5,827 | 5,765 | 5,791 | -22 | -0.4% | 920,100 |
2017/08/09 | 5,856 | 5,925 | 5,796 | 5,813 | -29 | -0.5% | 1,215,300 |
2017/08/08 | 5,865 | 5,873 | 5,818 | 5,842 | -23 | -0.4% | 831,500 |
2017/08/07 | 5,840 | 5,876 | 5,823 | 5,865 | +29 | +0.5% | 725,500 |
2017/08/04 | 5,872 | 5,883 | 5,823 | 5,836 | -66 | -1.1% | 1,120,100 |
2017/08/03 | 5,916 | 5,937 | 5,888 | 5,902 | -6 | -0.1% | 940,100 |
2017/08/02 | 5,887 | 5,928 | 5,879 | 5,908 | +24 | +0.4% | 979,400 |
2017/08/01 | 5,920 | 5,940 | 5,863 | 5,884 | -12 | -0.2% | 1,166,700 |
2017/07/31 | 5,956 | 6,003 | 5,800 | 5,896 | -60 | -1% | 2,005,400 |
2017/07/28 | 5,991 | 5,991 | 5,925 | 5,956 | -43 | -0.7% | 841,400 |
2017/07/27 | 6,059 | 6,077 | 5,991 | 5,999 | -59 | -1% | 1,140,200 |
2017/07/26 | 6,093 | 6,116 | 6,013 | 6,058 | +45 | +0.7% | 1,951,200 |
2017/07/25 | 6,144 | 6,168 | 5,981 | 6,013 | +103 | +1.7% | 2,650,900 |
2017/07/24 | 5,870 | 5,925 | 5,863 | 5,910 | -13 | -0.2% | 1,222,300 |
2017/07/21 | 5,993 | 5,999 | 5,918 | 5,923 | -90 | -1.5% | 1,106,400 |
2017/07/20 | 5,955 | 6,054 | 5,955 | 6,013 | +61 | +1% | 1,022,800 |
2017/07/19 | 5,936 | 5,997 | 5,936 | 5,952 | +8 | +0.1% | 764,700 |
2017/07/18 | 5,955 | 5,982 | 5,919 | 5,944 | -6 | -0.1% | 1,403,200 |
2017/07/14 | 5,976 | 5,989 | 5,924 | 5,950 | +37 | +0.6% | 1,020,900 |
2017/07/13 | 5,969 | 5,995 | 5,904 | 5,913 | -1 | ±0% | 1,148,600 |
2017/07/12 | 5,954 | 5,981 | 5,898 | 5,914 | -81 | -1.4% | 1,677,100 |
1751~
1800
件表示中 / 3586件
類似銘柄と比較する
現在ご覧いただいている「塩野義」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
塩野義 | 209,400円 | +5.7% | +3.9% | 2.74% | 10.42倍 | 1.38倍 |
|
抗HIV薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
大塚HD | 891,000円 | +14.4% | +120.8% | 1.35% | 20.00倍 | 1.83倍 |
|
国内製薬大手で抗精神病薬が主力。ポカリスエットなど機能性食品も拡大。世界90カ所に工場 |
アステラス薬 | 156,200円 | +12.2% | +180.3% | 4.74% | 55.93倍 | 1.83倍 |
|
医薬品国内2位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
エーザイ | 465,000円 | +1.7% | -2.9% | 3.44% | 30.51倍 | 1.60倍 |
|
神経系、がん領域に強み。認知症薬は米バイオジェンと、抗がん薬では米メルクと国際協業推進 |
協和キリン | 252,300円 | +11.3% | -5.4% | 2.30% | 19.42倍 | 1.53倍 |
|
キリン傘下。医薬品、バイオが主力。独自の抗体高活性化技術に強み。富士フイルムと提携 |
市場注目の銘柄
チャート関連のコラム